Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Larcaviximab

Catalog No. T77051 Copy Product Info
🥰Excellent
Larcaviximab (c4G7-N) is a chimeric monoclonal antibody of the IgG1 kappa class, specifically targeting the Ebola virus glycoprotein [1].

Larcaviximab

Copy Product Info
🥰Excellent
Catalog No. T77051

Larcaviximab (c4G7-N) is a chimeric monoclonal antibody of the IgG1 kappa class, specifically targeting the Ebola virus glycoprotein [1].

Larcaviximab
Cas No. 1792982-56-9
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$2472-4 weeks2-4 weeks
5 mg$6472-4 weeks2-4 weeks
10 mg$9872-4 weeks2-4 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Larcaviximab (c4G7-N) is a chimeric monoclonal antibody of the IgG1 kappa class, specifically targeting the Ebola virus glycoprotein [1].
Reactivity
Virus
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Uniprot ID
TargetEbola
Chemical Properties
Cas No.1792982-56-9
Antibody Information
IsotypeIgG1-R
Storage & Solubility Information
Storage-20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Larcaviximab | purchase Larcaviximab | Larcaviximab cost | order Larcaviximab